Is Vital Chemtech overvalued or undervalued?

As of 22 September 2025, the valuation grade for Vital Chemtech has moved from very expensive to expensive. The company is currently considered overvalued based on its financial metrics. Key ratios include a PE Ratio of 28.45, an EV to EBITDA of 18.84, and a ROE of 5.16%.
In comparison to its peers, Vital Chemtech's PE ratio is significantly lower than that of Solar Industries, which stands at 103.79, and Gujarat Fluoroch at 68.7, indicating that while Vital Chemtech is expensive, it is not as overvalued as some of its competitors. The recent stock performance shows a decline of 23.09% year-to-date, contrasting with a 6.59% increase in the Sensex, further supporting the view that the stock may be overvalued in the current market environment.